Terms: = Breast cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Clinical Outcome
21 results:
1. muc1 triggers lineage plasticity of Her2 positive mammary tumors.
Pang Z; Dong X; Deng H; Wang C; Liao X; Liao C; Liao Y; Tian W; Cheng J; Chen G; Yi H; Huang L
Oncogene; 2022 May; 41(22):3064-3078. PubMed ID: 35461328
[TBL] [Abstract] [Full Text] [Related]
2. First Evidence for a Role of Siglec-8 in breast cancer.
Trebo A; Ditsch N; Degenhardt T; Kuhn C; Rahmeh M; Schmoeckel E; Mayr D; Czogalla B; Kolben T; Meister S; Mahner S; Jeschke U; Hester A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670444
[TBL] [Abstract] [Full Text] [Related]
3. Patterns of biomarker expression in patients treated with primary endocrine therapy - a unique insight using core needle biopsy tissue microarray.
Parks RM; Albanghali MA; Syed BM; Green AR; Ellis IO; Cheung KL
Breast Cancer Res Treat; 2021 Feb; 185(3):647-655. PubMed ID: 33226492
[TBL] [Abstract] [Full Text] [Related]
4. Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR).
Sakai K; Tsuboi M; Kenmotsu H; Yamanaka T; Takahashi T; Goto K; Daga H; Ohira T; Ueno T; Aoki T; Nakagawa K; Yamazaki K; Hosomi Y; Kawaguchi K; Okumura N; Takiguchi Y; Sekine A; Haruki T; Yamamoto H; Sato Y; Akamatsu H; Seto T; Saeki S; Sugio K; Nishio M; Okabe K; Yamamoto N; Nishio K
Cancer Sci; 2021 Jan; 112(1):388-396. PubMed ID: 33185928
[TBL] [Abstract] [Full Text] [Related]
5. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.
Asano E; Okano K; Oshima M; Kagawa S; Kushida Y; Munekage M; Hanazaki K; Watanabe J; Takada Y; Ikemoto T; Shimada M; Suzuki Y;
J Surg Oncol; 2016 Jul; 114(1):119-27. PubMed ID: 27132476
[TBL] [Abstract] [Full Text] [Related]
6. Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial.
Antonilli M; Rahimi H; Visconti V; Napoletano C; Ruscito I; Zizzari IG; Caponnetto S; Barchiesi G; Iadarola R; Pierelli L; Rughetti A; Bellati F; Panici PB; Nuti M
Int J Oncol; 2016 Apr; 48(4):1369-78. PubMed ID: 26892612
[TBL] [Abstract] [Full Text] [Related]
7. breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
[TBL] [Abstract] [Full Text] [Related]
8. A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing breast cancer.
Menyhárt O; Santarpia L; Győrffy B
Curr Cancer Drug Targets; 2015; 15(8):665-83. PubMed ID: 26452383
[TBL] [Abstract] [Full Text] [Related]
9. [Matrix-producing metaplastic carcinoma: a clinicopathologic and prognostic analysis of 16 cases with review of literature].
Zhang Z; Bu H; Huang H; Zhang J; Lang Z; Zhao T; Wang J; Liao D; Wei B
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):528-32. PubMed ID: 25346122
[TBL] [Abstract] [Full Text] [Related]
10. Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts.
Syed BM; Green AR; Paish EC; Soria D; Garibaldi J; Morgan L; Morgan DA; Ellis IO; Cheung KL
Br J Cancer; 2013 Mar; 108(5):1042-51. PubMed ID: 23462719
[TBL] [Abstract] [Full Text] [Related]
11. EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients.
Alix-Panabières C
Recent Results Cancer Res; 2012; 195():69-76. PubMed ID: 22527495
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological and molecular characterization of colorectal micropapillary carcinoma.
Verdú M; Román R; Calvo M; Rodón N; García B; González M; Vidal A; Puig X
Mod Pathol; 2011 May; 24(5):729-38. PubMed ID: 21336262
[TBL] [Abstract] [Full Text] [Related]
13. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study.
Fisher CS; Cole DJ; Mitas M; Garrett-Meyer E; Metcalf JS; Gillanders WE; Mikhitarian K; Urist MM; Mann GB; Doherty G; Herrmann VM; Hill AD; Eremin O; El-Sheemy M; Orr RK; Valle AA; Henderson MA; Dewitty RL; Sugg SL; Frykberg E; Yeh K; Bell RM; Baker MK
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():312-20. PubMed ID: 20853052
[TBL] [Abstract] [Full Text] [Related]
14. Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patients.
Bölke E; Orth K; Gerber PA; Lammering G; Mota R; Peiper M; Matuschek C; Budach W; Rusnak E; Shaikh S; Dogan B; Prisack HB; Bojar H
Eur J Med Res; 2009 Aug; 14(8):359-63. PubMed ID: 19666396
[TBL] [Abstract] [Full Text] [Related]
15. muc1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer.
Khodarev NN; Pitroda SP; Beckett MA; MacDermed DM; Huang L; Kufe DW; Weichselbaum RR
Cancer Res; 2009 Apr; 69(7):2833-7. PubMed ID: 19318547
[TBL] [Abstract] [Full Text] [Related]
16. The expression pattern of muc1 (ema) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breast.
de Roos MA; van der Vegt B; Peterse JL; Patriarca C; de Vries J; de Bock GH; Wesseling J
Histopathology; 2007 Aug; 51(2):227-38. PubMed ID: 17650217
[TBL] [Abstract] [Full Text] [Related]
17. The expression pattern of muc1 (ema) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.
van der Vegt B; de Roos MA; Peterse JL; Patriarca C; Hilkens J; de Bock GH; Wesseling J
Histopathology; 2007 Sep; 51(3):322-35. PubMed ID: 17645748
[TBL] [Abstract] [Full Text] [Related]
18. Primary invasive micropapillary carcinoma of the colon.
Sakamoto K; Watanabe M; De La Cruz C; Honda H; Ise H; Mitsui K; Namiki K; Mikami Y; Moriya T; Sasano H
Histopathology; 2005 Nov; 47(5):479-84. PubMed ID: 16241995
[TBL] [Abstract] [Full Text] [Related]
19. Development of a hyperimmune anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer.
Winthrop MD; DeNardo SJ; DeNardo GL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3088s-3094s. PubMed ID: 10541348
[TBL] [Abstract] [Full Text] [Related]
20. Genetic markers as prognostic indicators in breast cancer.
Wolman SR; Pauley RJ; Mohamed AN; Dawson PJ; Visscher DW; Sarkar FH
Cancer; 1992 Sep; 70(6 Suppl):1765-74. PubMed ID: 1355402
[TBL] [Abstract] [Full Text] [Related]
[Next]
